Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 3.161% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CC(C)CN(CC(C)C)C(=O)COc1ccccc1C(N)=O
[b] c1ccc2c(C[C@@H]3CNCCN3CC3CCCCC3)cccc2c1
Answer: b. c1ccc2c(C[C@@H]3CNCCN3CC3CCCCC3)cccc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc2c(C[C@@H]3CNCCN3CC3CCCCC3)cccc2c1
c1ccc2c(C[C@@H]3CNCCN3CC3CCCCC3)cccc2c1
(2R)-1-(cyclohexylmethyl)-2-(naphthalen-1-ylmethyl)piperazine